Rheumatology Author Roy Fleischmann: Switching Between UPA and ADA
Dec 29, 2020
20:16
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Professor Roy Fleischmann, from the University of Texas Southwestern Medical Centre in Dallas, discusses data from the SELECT-COMPARE trial, where patients with RA were switched between upadacitinib and adalimumab in cases of insufficient response.
